<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Schmidiger S</submitter><funding>Swiss National Science Foundation</funding><funding>European &amp; Developing Countries Clinical Trials Partnership (EDCTP)</funding><pagination>e70004</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12332329</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55(8)</volume><pubmed_abstract>Human tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) remains a global public health threat. Granulomas constitute a hallmark of TB pathogenesis that can clear, contain, or exacerbate an infection. Containment is exploited by Mtb as a hideout to persist in a dormant, antibiotic-tolerant state, only to resuscitate upon immunosuppression. The immune determinants of a granulomatous response driving Mtb persistence remain elusive. We here generated ex vivo granuloma-like structures from peripheral blood mononuclear cell specimens of TB patients and applied high-dimensional mass cytometry to elucidate immune factors prompting Mtb dormancy. Compared with healthy controls, patient-derived specimens rapidly forced Mtb to become dormant-like ex vivo. This observation correlated with an</pubmed_abstract><journal>European journal of immunology</journal><pubmed_title>Granulysin Antimicrobial Activity Promotes Dormancy in Mycobacterium tuberculosis.</pubmed_title><pmcid>PMC12332329</pmcid><funding_grant_id>197838 and 177163</funding_grant_id><pubmed_authors>Mfinanga E</pubmed_authors><pubmed_authors>McCaffrey EF</pubmed_authors><pubmed_authors>Haraka F</pubmed_authors><pubmed_authors>Reither K</pubmed_authors><pubmed_authors>Sasamalo M</pubmed_authors><pubmed_authors>Hameed OA</pubmed_authors><pubmed_authors>Hiza H</pubmed_authors><pubmed_authors>Hella J</pubmed_authors><pubmed_authors>Walch M</pubmed_authors><pubmed_authors>Fellay J</pubmed_authors><pubmed_authors>Gagneux S</pubmed_authors><pubmed_authors>Schmidt JM</pubmed_authors><pubmed_authors>Tumbo A</pubmed_authors><pubmed_authors>Portevin D</pubmed_authors><pubmed_authors>Schmidiger S</pubmed_authors><pubmed_authors>Carballido JM</pubmed_authors><pubmed_authors>Arbues A</pubmed_authors><pubmed_authors>Mpina M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Granulysin Antimicrobial Activity Promotes Dormancy in Mycobacterium tuberculosis.</name><description>Human tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) remains a global public health threat. Granulomas constitute a hallmark of TB pathogenesis that can clear, contain, or exacerbate an infection. Containment is exploited by Mtb as a hideout to persist in a dormant, antibiotic-tolerant state, only to resuscitate upon immunosuppression. The immune determinants of a granulomatous response driving Mtb persistence remain elusive. We here generated ex vivo granuloma-like structures from peripheral blood mononuclear cell specimens of TB patients and applied high-dimensional mass cytometry to elucidate immune factors prompting Mtb dormancy. Compared with healthy controls, patient-derived specimens rapidly forced Mtb to become dormant-like ex vivo. This observation correlated with an</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-04-15T19:07:53.17Z</modification><creation>2026-04-07T14:00:53.686Z</creation></dates><accession>S-EPMC12332329</accession><cross_references><pubmed>40776481</pubmed><doi>10.1002/eji.70004</doi></cross_references></HashMap>